As shown in Table 1, by analyzing the NPC2 expression level and clinicopathological factors in 160 GBM patients, we found that NPC2 was correlated with patents’ age (p value = 0.04) and alive status (p value = 0.039). This evidence concerns the gene NPC2 and glioblastoma.